CNST

Constellation Pharmaceuticals, Inc.
CNST

Overview Fund Activity
Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

100 hedge funds and large institutions have $1.8B invested in Constellation Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+52
Holders Change %
+108.33%
% of All Funds
1.97%
Holding in Top 10
12
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+300%
% of All Funds
0.24%
New
55
Increased
26
Reduced
12
Closed
3
Calls
$2.65M
Puts
$807K
Net Calls
+$1.85M
Net Calls Change
+$1.85M

Top Buyers

1
ACA
Avoro Capital Advisors
New York
+$172M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$133M
3
VMI
VHCP Management III
New York
+$115M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$91.7M
5
GPP
Great Point Partners
Connecticut
+$53.5M

Top Sellers

1
ROTUOC
Regents of the University of California
California
-$25.9M
2
CC
Casdin Capital
New York
-$14.7M
3
O
OrbiMed
New York
-$5.4M
4
PAWC
P.A.W. Capital
Connecticut
-$2.36M
5
HA
HHLR Advisors
Cayman Islands
-$1.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
HA
101
HHLR Advisors
Cayman Islands
– -$1.6M -246,883 Closed
GW
102
GW & Wade
Massachusetts
– -$79K -12,262 Closed
1 2 3 4
5